Human thymidylate synthase with loop 181-197 stabilized in an inactive conformation: ligand interactions,
BeiBei Luo1, Jayanthi Repalli, Al-Motassem Yousef
1Department of Pharmaceutical Sciences, University of South Carolina, Columbia, South Carolina 29208, USA.
Abstract:
Thymidylate synthase (TS) is a well-validated cancer target that undergoes conformational switching between active and inactive states. Two mutant human TS (hTS) proteins are predicted from crystal structures to be stabilized in an inactive conformation to differing extents, with M190K populating the inactive conformation to a greater extent than A191K. Studies of intrinsic fluorescence and circular dichroism revealed that the structures of the mutants differ from those of hTS. Inclusion of the substrate dUMP was without effect on M190K but induced structural changes in A191K that are unique, relative to hTS. The effect of strong stabilization in an inactive conformation on protein phosphorylation by casein kinase 2 (CK2) was investigated. M190K was highly phosphorylated by CK2 relative to an active-stabilized mutant, R163K hTS. dUMP had no detectable effect on phosphorylation of M190K; however, dUMP inhibited phosphorylation of hTS and R163K. Studies of temperature dependence of catalysis revealed that the E(act) and temperature optimum are higher for A191K than hTS. The potency of the active-site inhibitor, raltitrexed, was lower for A191K than hTS. The response of A191K to the allosteric inhibitor, propylene diphosphonate (PDPA) was concentration dependent. Mixed inhibition was observed at low concentrations; at higher concentrations, A191K exhibited nonhyperbolic behavior with respect to dUMP and inhibition of catalysis was reversed by substrate saturation. In summary, inactive-stabilized mutants differ from hTS in thermal stability and response to substrates and PDPA. Importantly, phosphorylation of hTS by CK2 is selective for the inactive conformation, providing the first indication of physiological relevance for conformational switching.
Insights
Inactive-stabilized thymidylate synthase (TS) mutants exhibit altered structures, substrate responses, and phosphorylation patterns. This suggests a physiological role for TS conformational switching in cancer therapy.
Area of Science:
- Biochemistry
- Molecular Biology
- Enzymology
Background:
- Thymidylate synthase (TS) is a crucial cancer target.
- TS exhibits conformational switching between active and inactive states.
- Mutant hTS proteins (M190K, A191K) are stabilized in inactive conformations.
Purpose of the Study:
- Investigate structural and functional differences of inactive-stabilized hTS mutants.
- Determine the impact of conformational stabilization on protein phosphorylation.
- Explore the physiological relevance of TS conformational switching.
Main Methods:
- Intrinsic fluorescence and circular dichroism spectroscopy.
- Enzyme kinetics and inhibitor potency assays.
- Casein kinase 2 (CK2) phosphorylation studies.
- Temperature dependence analysis of catalysis.
Main Results:
- Mutants M190K and A191K display unique structural and thermal properties compared to wild-type hTS.
- Substrate dUMP affects A191K structure but not M190K.
- M190K shows high CK2 phosphorylation, independent of dUMP.
- A191K exhibits altered catalytic activity, inhibitor response, and substrate interaction.
- CK2 phosphorylation of hTS is selective for the inactive conformation.
Conclusions:
- Inactive-stabilized hTS mutants exhibit distinct biochemical and biophysical characteristics.
- Protein phosphorylation by CK2 is conformation-specific, highlighting physiological relevance.
- Conformational switching of TS is a key factor in its biological function and potential therapeutic targeting.
Related Concept Videos
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
TGF - β Signaling Pathway
ATP Synthase: Mechanism
Ligand Binding and Linkage
Amplifying Signals via Enzymatic Cascade

